Pharma Gmbh Salmon serves as Executive at Vallon Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Pharma Gmbh Salmon has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 12, 2021 involved transacting 47,063 shares valued at $301.2K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 12, 2021 | VLON | $301.2K | Other | 47,063 | $6.40 | Discretionary |
Pharma Gmbh Salmon currently holds 47,063 shares of Vallon Pharmaceuticals, Inc. (VLON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pharma Gmbh Salmon has been a net neutral trader of VLON stock. They have purchased $0 and sold $0 worth of shares.
Pharma Gmbh Salmon's most recent insider trade was on Feb 12, 2021, when they sold 47,063 shares at $6.40 per share.
Get notified when new Form 4 filings are submitted